Two recent meta-analyses considered vitamin D supplementation and IBS. The first included four randomized, placebo-controlled trials involving 335 participants. The researchers assessed vitamin D efficacy in IBS with outcomes before and after supplementation using the irritable bowel syndrome severity scoring system (IBS-SSS), IBS-QoL, and IBS-TS.
IBS-SSS score in the intervention group showed greater improvement after vitamin D supplementation compared with the placebo group (which the second team did not find, see below). Participants receiving vitamin D also showed IBS-QoL improvement. The researchers did not evaluate the efficacy of vitamin D intervention in IBS-TS for sensitivity reasons.
The second systematic review and meta-analysis included six randomized controlled trials with 616 patients assessing vitamin D efficacy in IBS. IBS-SSS was the primary outcome and IBS-QoL and serum level of calcifediol 25(OH)D were the secondary outcomes; this team did not consider IBS-TS.
The team found no difference between vitamin D and placebo in IBS-SSS scores, unlike the first analysis. The IBS-Qol and serum 25(OH)D scores were both favored in the pooled analysis for vitamin D over placebo.
Learn more about IBS.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Romesh Khardori. Rapid Review Quiz: Vitamin D - Medscape - Sep 06, 2022.